Brief: Sesen Bio Reports Q3 Earnings Per Share Of $0.36
Nov 8 (Reuters) - Sesen Bio Inc SESN.O :
* SESEN BIO REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND
BUSINESS UPDATE
* SESEN BIO INC - QTRLY CASH, CASH EQUIVALENTS AND
RESTRICTED CASH
WERE $175.3 MILLION AS OF SEP 30 VERSUS $55.4 MILLION IN DEC 30
* SESEN BIO INC - Q3 EARNINGS PER SHARE $0.36
Source text for Eikon: ID:nBw2RsW59a
Further company coverage: SESN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary